These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
187 related items for PubMed ID: 10925282
1. Antitumor effects of the mouse chemokine 6Ckine/SLC through angiostatic and immunological mechanisms. Vicari AP, Ait-Yahia S, Chemin K, Mueller A, Zlotnik A, Caux C. J Immunol; 2000 Aug 15; 165(4):1992-2000. PubMed ID: 10925282 [Abstract] [Full Text] [Related]
2. Secondary lymphoid tissue chemokine mediates T cell-dependent antitumor responses in vivo. Sharma S, Stolina M, Luo J, Strieter RM, Burdick M, Zhu LX, Batra RK, Dubinett SM. J Immunol; 2000 May 01; 164(9):4558-63. PubMed ID: 10779757 [Abstract] [Full Text] [Related]
3. Soluble expression of recombinant human secondary lymphoid chemokine (SLC) in E. coli and research on its in vitro and in vivo bioactivity. Chun L, Yin CC, Song JZ, Liu MX, Piao JH, Lin Q, Wang XB, Huang HL. J Biochem; 2004 Dec 01; 136(6):769-76. PubMed ID: 15671487 [Abstract] [Full Text] [Related]
4. Synergistic antitumor effect by coexpression of chemokine CCL21/SLC and costimulatory molecule LIGHT. Hisada M, Yoshimoto T, Kamiya S, Magami Y, Miyaji H, Yoneto T, Tamada K, Aoki T, Koyanagi Y, Mizuguchi J. Cancer Gene Ther; 2004 Apr 01; 11(4):280-8. PubMed ID: 15002032 [Abstract] [Full Text] [Related]
5. The murine CC chemokine, 6C-kine, inhibits tumor growth and angiogenesis in a human lung cancer SCID mouse model. Arenberg DA, Zlotnick A, Strom SR, Burdick MD, Strieter RM. Cancer Immunol Immunother; 2001 Jan 01; 49(11):587-92. PubMed ID: 11225989 [Abstract] [Full Text] [Related]
6. Herpes simplex virus (HSV) amplicon-mediated codelivery of secondary lymphoid tissue chemokine and CD40L results in augmented antitumor activity. Tolba KA, Bowers WJ, Muller J, Housekneckt V, Giuliano RE, Federoff HJ, Rosenblatt JD. Cancer Res; 2002 Nov 15; 62(22):6545-51. PubMed ID: 12438249 [Abstract] [Full Text] [Related]
7. 6-C-kine (SLC), a lymphocyte adhesion-triggering chemokine expressed by high endothelium, is an agonist for the MIP-3beta receptor CCR7. Campbell JJ, Bowman EP, Murphy K, Youngman KR, Siani MA, Thompson DA, Wu L, Zlotnik A, Butcher EC. J Cell Biol; 1998 May 18; 141(4):1053-9. PubMed ID: 9585422 [Abstract] [Full Text] [Related]
8. In vivo manipulation of dendritic cell migration and activation to elicit antitumour immunity. Vicari AP, Vanbervliet B, Massacrier C, Chiodoni C, Vaure C, Aït-Yahia S, Dercamp C, Matsos F, Reynard O, Taverne C, Merle P, Colombo MP, O'Garra A, Trinchieri G, Caux C. Novartis Found Symp; 2004 May 18; 256():241-54; discussion 254-69. PubMed ID: 15027495 [Abstract] [Full Text] [Related]
9. CCL21 chemokine regulates chemokine receptor CCR7 bearing malignant melanoma cells. Takeuchi H, Fujimoto A, Tanaka M, Yamano T, Hsueh E, Hoon DS. Clin Cancer Res; 2004 Apr 01; 10(7):2351-8. PubMed ID: 15073111 [Abstract] [Full Text] [Related]
10. Cutting edge: species specificity of the CC chemokine 6Ckine signaling through the CXC chemokine receptor CXCR3: human 6Ckine is not a ligand for the human or mouse CXCR3 receptors. Jenh CH, Cox MA, Kaminski H, Zhang M, Byrnes H, Fine J, Lundell D, Chou CC, Narula SK, Zavodny PJ. J Immunol; 1999 Apr 01; 162(7):3765-9. PubMed ID: 10201891 [Abstract] [Full Text] [Related]
11. The chemokine SLC is expressed in T cell areas of lymph nodes and mucosal lymphoid tissues and attracts activated T cells via CCR7. Willimann K, Legler DF, Loetscher M, Roos RS, Delgado MB, Clark-Lewis I, Baggiolini M, Moser B. Eur J Immunol; 1998 Jun 01; 28(6):2025-34. PubMed ID: 9645384 [Abstract] [Full Text] [Related]
12. The CC chemokine 6Ckine binds the CXC chemokine receptor CXCR3. Soto H, Wang W, Strieter RM, Copeland NG, Gilbert DJ, Jenkins NA, Hedrick J, Zlotnik A. Proc Natl Acad Sci U S A; 1998 Jul 07; 95(14):8205-10. PubMed ID: 9653165 [Abstract] [Full Text] [Related]
15. T cell-dependent antitumor immunity mediated by secondary lymphoid tissue chemokine: augmentation of dendritic cell-based immunotherapy. Kirk CJ, Hartigan-O'Connor D, Nickoloff BJ, Chamberlain JS, Giedlin M, Aukerman L, Mule JJ. Cancer Res; 2001 Mar 01; 61(5):2062-70. PubMed ID: 11280767 [Abstract] [Full Text] [Related]
16. SLC/exodus2/6Ckine/TCA4 induces chemotaxis of hematopoietic progenitor cells: differential activity of ligands of CCR7, CXCR3, or CXCR4 in chemotaxis vs. suppression of progenitor proliferation. Kim CH, Broxmeyer HE. J Leukoc Biol; 1999 Sep 01; 66(3):455-61. PubMed ID: 10496316 [Abstract] [Full Text] [Related]
17. Augmented antitumor activity of a secondary lymphoid-tissue chemokine (SLC)-interleukin (IL) 2 fusion protein in mouse. Nakahara K, Sakata T. J Gene Med; 2003 Jun 01; 5(6):463-71. PubMed ID: 12797111 [Abstract] [Full Text] [Related]
18. The CC chemokine receptor-7 ligands 6Ckine and macrophage inflammatory protein-3 beta are potent chemoattractants for in vitro- and in vivo-derived dendritic cells. Kellermann SA, Hudak S, Oldham ER, Liu YJ, McEvoy LM. J Immunol; 1999 Apr 01; 162(7):3859-64. PubMed ID: 10201903 [Abstract] [Full Text] [Related]
19. Augmented expression of secondary lymphoid tissue chemokine and EBI1 ligand chemokine in Crohn's disease. Kawashima D, Oshitani N, Jinno Y, Watanabe K, Nakamura S, Higuchi K, Arakawa T. J Clin Pathol; 2005 Oct 01; 58(10):1057-63. PubMed ID: 16189151 [Abstract] [Full Text] [Related]
20. Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. Gunn MD, Kyuwa S, Tam C, Kakiuchi T, Matsuzawa A, Williams LT, Nakano H. J Exp Med; 1999 Feb 01; 189(3):451-60. PubMed ID: 9927507 [Abstract] [Full Text] [Related] Page: [Next] [New Search]